Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G M Dallinga-Thie

Showing results (11-20 of 85) with videos related to

Pageof 9
Sort By:
European Journal of Clinical Investigation|December 12, 2001
Two newly identified SNPs in the APO AI-CIII intergenic region are strongly associated with familial combined hyperlipidaemiaM Groenendijk, R M Cantor, H Funke, et al.
The International Journal of Biochemistry|January 1, 1986
Comparison of the metabolic behavior of rat apolipoproteins A-I and A-IV, isolated from both lymph chylomicrons and serum high density lipoproteinsG M Dallinga-Thie, F M van't Hooft, A van Tol
Expert Review of Cardiovascular Therapy|June 9, 2020
Targeting apoC-III and ANGPTL3 in the treatment of hypertriglyceridemiaN S Nurmohamed, G M Dallinga-Thie, E S G Stroes
Biochimica Et Biophysica Acta|March 24, 2009
Plasma pre beta-HDL formation is decreased by atorvastatin treatment in type 2 diabetes mellitus: Role of phospholipid transfer proteinG M Dallinga-Thie, A van Tol, R P F Dullaart, et al.
Atherosclerosis|February 23, 2013
Phospholipid transfer protein, an emerging cardiometabolic risk marker: is it time to intervene?R P F Dullaart, A van Tol, G M Dallinga-Thie
Nederlands Tijdschrift Voor Geneeskunde|October 26, 1996
[Familial combined hyperlipidemia]T W de Bruin, G M Dallinga-Thie, D W Erkelens
Current Atherosclerosis Reports|February 25, 2005
Remnant lipoproteins and atherosclerosisThB Twickler, G M Dallinga-Thie, M J Chapman, et al.
Biochimica Et Biophysica Acta|March 27, 1985
Leupeptin as a tool for the detection of the sites of catabolism of rat high-density lipoprotein apolipoproteins A-I and EF M van 't Hooft, G M Dallinga-Thie, A van Tol
Arteriosclerosis (Dallas, Tex.)|May 1, 1986
Tissue sites of degradation of high density lipoprotein apolipoprotein A-IV in ratsG M Dallinga-Thie, F M Van 't Hooft, A Van Tol
Clinical and Experimental Immunology|February 18, 2014
Intestinal microbiota and faecal transplantation as treatment modality for insulin resistance and type 2 diabetes mellitusS D Udayappan, A V Hartstra, G M Dallinga-Thie, et al.
Pageof 9

Showing results (11-20 of 85) with videos related to

Sort By:
Pageof 9
European Journal of Clinical Investigation|December 12, 2001
Two newly identified SNPs in the APO AI-CIII intergenic region are strongly associated with familial combined hyperlipidaemiaM Groenendijk, R M Cantor, H Funke, et al.
The International Journal of Biochemistry|January 1, 1986
Comparison of the metabolic behavior of rat apolipoproteins A-I and A-IV, isolated from both lymph chylomicrons and serum high density lipoproteinsG M Dallinga-Thie, F M van't Hooft, A van Tol
Expert Review of Cardiovascular Therapy|June 9, 2020
Targeting apoC-III and ANGPTL3 in the treatment of hypertriglyceridemiaN S Nurmohamed, G M Dallinga-Thie, E S G Stroes
Biochimica Et Biophysica Acta|March 24, 2009
Plasma pre beta-HDL formation is decreased by atorvastatin treatment in type 2 diabetes mellitus: Role of phospholipid transfer proteinG M Dallinga-Thie, A van Tol, R P F Dullaart, et al.
Atherosclerosis|February 23, 2013
Phospholipid transfer protein, an emerging cardiometabolic risk marker: is it time to intervene?R P F Dullaart, A van Tol, G M Dallinga-Thie
Nederlands Tijdschrift Voor Geneeskunde|October 26, 1996
[Familial combined hyperlipidemia]T W de Bruin, G M Dallinga-Thie, D W Erkelens
Current Atherosclerosis Reports|February 25, 2005
Remnant lipoproteins and atherosclerosisThB Twickler, G M Dallinga-Thie, M J Chapman, et al.
Biochimica Et Biophysica Acta|March 27, 1985
Leupeptin as a tool for the detection of the sites of catabolism of rat high-density lipoprotein apolipoproteins A-I and EF M van 't Hooft, G M Dallinga-Thie, A van Tol
Arteriosclerosis (Dallas, Tex.)|May 1, 1986
Tissue sites of degradation of high density lipoprotein apolipoprotein A-IV in ratsG M Dallinga-Thie, F M Van 't Hooft, A Van Tol
Clinical and Experimental Immunology|February 18, 2014
Intestinal microbiota and faecal transplantation as treatment modality for insulin resistance and type 2 diabetes mellitusS D Udayappan, A V Hartstra, G M Dallinga-Thie, et al.
Pageof 9